Medical News

RSS

Massachusetts looks to other states for website fixes

Among possible ways to resolve the continuing issues, state officials are contemplating the possibility of buying or leasing technology from states where the online insurance marketplace is working. They also are considering scrapping the current website and starting over. News outlets also track developments in Maryland, California and Illinois.

10 Mar 2014

Majority of Latinas unaware of diabetes risk

Approximately 5.5 million Latinas suffer from elevated fasting plasma glucose (FPG) and nearly 4 million of those women were never told by a healthcare provider they were at risk for diabetes, pre-diabetes, or were borderline for diabetes.

10 Mar 2014

Harvard Review of Psychiatry provides updates on ASD research

Recent years have seen exciting progress in key areas of research on autism spectrum disorders (ASD): from possible genetic causes, to effective treatments for common symptoms and clinical problems, to promoting success for young people with ASD entering college. Updates on these and other advances in ASD research are presented in the March special issue of Harvard Review of Psychiatry.

10 Mar 2014

Study finds that older patients are undertreated

Older people globally are being denied proper access to cancer care, according to an editorial by Queen's University Belfast academic, Professor Mark Lawler of the Centre for Cancer Research and Cell Biology.

10 Mar 2014

Study examines impact of the elimination of preferred pharmacy networks on Medicare Part D program

A new actuarial study released by The Pharmaceutical Care Management Association examining the impact proposed changes to the Medicare prescription drug program finds that eliminating preferred pharmacy networks in Part D would increase premiums by approximately $63 annually for over 75 percent of Part D enrollees and raise overall program costs by an estimated $24 billion over the next ten years.

10 Mar 2014

EOS imaging announces CE mark of hipEOS

EOS imaging, the pioneer in orthopaedic 2D/3D imaging, announced today the CE mark of hipEOS, a 3D hip arthroplasty planning software based on EOS biplanar 3D imaging.

10 Mar 2014

Survey credits health law for lowered uninsured rate

News outlets report on implementation issues including the declining rate of uninsured people, confusion created by recent administrative changes and a union's assertion that the law will increase inequality.

10 Mar 2014

A pill may provide hope to relapsed leukemia and lymphoma patients

A pill that suppresses a key regulator of cancer growth may provide hope to relapsed leukemia and lymphoma patients running out of treatment options for their aggressive, treatment-resistant disease, according to three reports published online today in Blood, the journal of the American Society of Hematology.

10 Mar 2014

Sentinel node biopsy increases survival rates in melanoma patients

Moffitt Cancer Center researchers have been instrumental in making significant improvements to the diagnostic procedure called sentinel node biopsy for melanoma patients and teaching this procedure to physicians from around the world.

10 Mar 2014

Regado receives Fast Track designation from FDA for REG1

Regado Biosciences, Inc., a biopharmaceutical company focused on the development of actively controllable therapeutics, today announced that the United States Food and Drug Administration has designated REG1 for anticoagulant therapy to be used in patients with coronary artery disease during percutaneous coronary interventions (PCI) as a Fast Track development program.

10 Mar 2014

Risk-based approach for screening men at increased risk of prostate cancer

The UK needs to invest in testing for those men most at risk of prostate cancer rather than follow a cast-the-net-wide approach targeting the whole population, a leading scientist from The University of Manchester - part of Manchester Cancer Research Centre - has argued at an international conference this week.

From The University of Manchester 10 Mar 2014

Skin cancer may increase risk of other cancers later in life

Australian author on the paper, Professor Rodney Sinclair, Professor of Medicine at the University of Melbourne and Director of Dermatology at Epworth HealthCare said that the risk decreased significantly with increasing age, but it remains higher compared with individuals who have never had NMSC.

10 Mar 2014

FDA accepts Lundbeck's carbamazepine NDA for review

Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.

10 Mar 2014

ABC Varro E. Tyler Commercial Investment in Phytomedicinal Research Award presented to Wakunaga

The American Botanical Council has presented its 2013 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award to Wakunaga Pharmaceutical Company, Ltd., of Osaka, Japan. Since its founding in 1955, the company has been committed to rigorous scientific and clinical research of its products, including its top-selling, clinically researched odorless Aged Garlic Extract¨.

10 Mar 2014

Bosch Healthcare selects Brain Resource's MyBrainSolutions for use in telehealth solution

Brain Resource has announced today that Robert Bosch Healthcare Systems, Inc. (headquarters in Palo Alto, California, USA), the market leader in evidence-based telehealth solutions, has added MyBrainSolutions to their newly launched Health Buddy Web solution for the monitoring, education, and management of people living with chronic conditions.

10 Mar 2014

BerGenBio receives grant to study novel therapeutics for inhibiting epithelial-mesenchymal transition

BerGenBio AS, an oncology biopharmaceutical company, is pleased to announce the award of a NOK 13 million grant from the Research Council of Norway's User-driven Research based Innovation programme (BIA) to help fund research into novel therapeutics for inhibiting tumor epithelial-mesenchymal transition (EMT), a key driver of metastasis (cancer spread) and a mechanism of drug-resistance.

10 Mar 2014

Antares Pharma announces launch of OTREXUP to Dermatologists

Antares Pharma, Inc. today announced LEO Pharma's launch of OTREXUP to Dermatologists, the first U.S. Food and Drug Administration approved subcutaneous (SC) methotrexate (MTX) product for once weekly self-administration with an easy-to-use, single dose, disposable auto injector.

10 Mar 2014

MHS, MedStar Georgetown University Hospital team up to implement OptIC Inventory Service

Management Health Solutions has partnered with MedStar Georgetown University Hospital to utilize its OptIC Inventory Service. The implementation of the OptIC Inventory Service will enhance visibility and accountability in the hospital's supply chain. MHS' comprehensive technology and specialty services platform will help MedStar Georgetown realize significant, recurring, hard-dollar, P&L savings on their supply spend.

10 Mar 2014

Mortality in prostate cancer lower in areas with frequent use of PSA testing

Mortality in prostate cancer is lower in areas with frequent use of PSA testing compared with areas with little testing shows a study published online today in Journal of the National Cancer Institute by researchers from Umeå University, Sweden and Memorial Sloan Kettering Cancer Center, New York, NY, USA.

10 Mar 2014

Men who have poorer cardiovascular fitness at 18 years more often suffer from dementia before 60

Men who at the age of 18 years have poorer cardiovascular fitness and/or a lower IQ more often suffer from dementia before the age of 60. This is shown in a recent study encompassing more than one million Swedish men.

10 Mar 2014